David A. Siegel X Biotech Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in X Biotech Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 17,400 shares of XBIT stock, worth $49,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,400Holding current value
$49,416% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding XBIT
# of Institutions
55Shares Held
4.53MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA461KShares$1.31 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$705,0860.0% of portfolio
-
State Street Corp Boston, MA230KShares$652,3330.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $86.4M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...